- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| So | VITURA HEALTH LIMITED: Strategy Reset delivers positive Q1 results | - | ASX | ||
| 25.10. | VITURA HEALTH LIMITED: Updated Proxy Form | - | ASX | ||
| 23.10. | VITURA HEALTH LIMITED: Shareholder statement | 2 | ASX | ||
| 23.10. | VITURA HEALTH LIMITED: Board renewal and Notice of 2024 AGM | 1 | ASX | ||
| 21.10. | VITURA HEALTH LIMITED: 2024 Annual Report | - | ASX | ||
| 16.10. | VITURA HEALTH LIMITED: Vitura settles dispute with Code4 Cannabis | - | ASX | ||
| 09.09. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 08.09. | VITURA HEALTH LIMITED: Appointment of Chief Technology Officer | - | ASX | ||
| 06.09. | VITURA HEALTH LIMITED: Date for 2024 Annual General Meeting | - | ASX | ||
| 06.09. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 04.09. | VITURA HEALTH LIMITED: Investor presentation | - | ASX | ||
| 03.09. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 29.08. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 28.08. | VITURA HEALTH LIMITED: ASX Appendix 4G - 30 June 2024 | - | ASX | ||
| 28.08. | VITURA HEALTH LIMITED: 2024 Financial Report | - | ASX | ||
| 28.08. | VITURA HEALTH LIMITED: FY2024 Financial Results | - | ASX | ||
| 28.08. | VITURA HEALTH LIMITED: ASX Appendix 4E - 30 June 2024 | - | ASX | ||
| 27.08. | VITURA HEALTH LIMITED: Geoff Cockerill appointed CEO of Vitura | - | ASX | ||
| 01.08. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 5,075 | -0,88 % | Unglaubliche Prognose für Montag setzt Aurora Cannabis Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
| TILRAY BRANDS | 1,511 | -0,49 % | Unglaubliche Prognose für Montag setzt Tilray Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
| ORGANIGRAM | 1,600 | -0,12 % | Paolo De Luca Sells 12,014 Shares of Organigram Holdings Inc. (TSE:OGI) Stock | ||
| SNDL | 1,939 | -0,21 % | SNDL Inc.: SNDL Successfully Completes Privatization of Nova Cannabis Inc. and Welcomes New Director | CALGARY, AB, Oct. 21, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL") and Nova Cannabis Inc. (TSX: NOVC) ("Nova") are pleased to announce the closing of the previously announced plan of arrangement... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,003 | 0,00 % | Mydecine Innovations Group Inc - Suspension of Trading | Mydecine Innovations Group Inc - Suspension of Trading
PR Newswire
LONDON, United Kingdom, October 10
SUSPENSION OF TRADINGVancouver, British Columbia, 10 October 2024-... ► Artikel lesen | |
| BIONANO GENOMICS | 0,280 | -3,35 % | Bionano Genomics: Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules | ||
| TONIX PHARMACEUTICALS | 0,139 | -4,61 % | Tonix berichtet über vielversprechende Daten zu Mpox-Impfstoffkandidat | ||
| HIGH TIDE | 2,650 | +0,19 % | Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures | ||
| ACHIEVE LIFE SCIENCES | 4,315 | -0,58 % | Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline | SEATTLE and VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization... ► Artikel lesen | |
| JAGUAR HEALTH | 1,055 | +0,48 % | Jaguar Health, Inc.: Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting | It is estimated that 10-15% of people in the United States have IBS SAN FRANCISCO, CA / ACCESSWIRE / October 29, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.10.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 24.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.10.2024ISIN NameAU0000114977 BOOKTOPIA... ► Artikel lesen | |
| MEDIPHARM LABS | 0,044 | -7,50 % | MediPharm Labs Corp.: MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA as Gross Profit Continues to Improve | TORONTO, Aug. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,125 | -14,97 % | Argent Biopharma Ltd - September 2024 Quarterly Report | ||
| AUSCANN | - | - | AUSCANN GROUP HOLDINGS LTD: Removal from Official List - Annual Listing Fees | ||
| NABRIVA THERAPEUTICS | - | - | Meitheal gains rights to CONTEPO from Nabriva in North America |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,004 (-7,41 %) liegt der Kurs bei 0,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.
